Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • ADHD: Scientists discover brain's anti-distraction system

  • Modified stem cells offer potential pathway to treat Alzheimer's disease

  • Scientists explain how memories stick together

  • In old age, lack of emotion, interest may signal brain is shrinking

  • Book early, after work if you want to enjoy your next hotel stay

  • Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

  • Distracted driving among teens threatens public health and safety

  • Conceptual representation in the brain: Towards mind-reading?

  • Common links between neurodegenerative diseases identified

  • For resetting circadian rhythms, neural cooperation is key

  •